Celgene, TESARO Deals Positive for SMID Cap Biotech - SunTrust

January 3, 2019 10:34 AM
SunTrust Robinson Humphrey's biotech team views the acquisition of Celgene, which follows December’s acquisition of TESARO, by large pharma as ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)


Analyst Comments

Next Articles